Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the otw_tsw domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/wp-includes/functions.php on line 6114
2012 – Q3 – U.S. Stem Cell, Inc

2012 – Q3

8/3/2012
BIOHEART RENEGOTIATES COMPANY NOTE WITH FAVORABLE TERMS
Bioheart, Inc. (BHRT.OB) has renegotiated the terms of a Company note in the amount of $572,000 held by NorthStar Biotech, LLC, a consortium of Bioheart Directors and Shareholders, led by Bioheart Director Chuck Hart.

8/2/2012
BIOHEART RECEIVES $ 2 MILLION TERM SHEET
INVESTMENT OFFER FROM GRUPO VITALMEX, A GLOBAL
LEADER IN HEALTHCARE IN LATIN AMERICA AND EUROPE
Bioheart, Inc. (BHRT.OB) announced today it has received a non-binding term sheet and investment offer in the amount of $ 2 million from Grupo Vitalmex in Mexico, a global leader in the healthcare sector in Latin America and
Europe (www.vitalmex.com.mx).